The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study.
Yung-Yeh SuYing-Jui ChaoChih-Jung WangTing-Kai LiaoPing-Jui SuChien-Jui HuangNai-Jung ChiangYu-Ting YuHong-Ming TsaiLi-Tzong ChenYan-Shen ShanPublished in: International journal of surgery (London, England) (2023)
Our study demonstrates that NAC is superior to UR in resectable pancreatic cancer with better survival.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- rectal cancer
- squamous cell carcinoma
- sentinel lymph node
- minimally invasive
- lymph node
- radiation therapy
- physical activity
- coronary artery bypass
- liver metastases
- transcription factor
- risk factors
- surgical site infection
- acute coronary syndrome
- percutaneous coronary intervention